This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thukral, S K Articles by Fields, S Search for Related Content PubMed PubMed Citation Articles by Thukral, S K Articles by Fields, S

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 December; 14(12): 8315-8321

Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.

Department of Developmental Biology, AMGEN, Thousand Oaks, California 91320.

ABSTRACT

We identified a minimal domain of human p53 required for the transactivation of a p53 response element in Saccharomyces cerevisiae. This domain contains the central region of p53 sufficient for specific DNA binding, which colocalizes with the region responsible for binding simian virus 40 large T antigen, 53BP1, and 53BP2. Thirty amino acid positions, including natural mutational hot spots (R175, R213, R248, R249, and R273), in the minimal DNA-binding domain were mutated by alanine substitution. Alanine substitutions at positions R213, R248, R249, D281, R282, R283, E286, and N288 affected transactivation but allowed binding to at least one of the three interacting proteins; these amino acids may be involved in amino acid-base pair contacts. Surprisingly, alanine substitution at the mutational hot spot R175 did not affect DNA binding, transactivation, or T-antigen binding, although it nearly eliminated binding to 53BP1 and 53BP2. Mutation of H168 significantly affected only T-antigen binding, and mutation of E285 affected only 53BP1 binding. Thus, we implicate specific residues of p53 in different DNA and protein interactions.

This article has been cited by other articles:

• Joerger, A. C., Ang, H. C., Veprintsev, D. B., Blair, C. M., Fersht, A. R. (2005). Structures of p53 Cancer Mutants and Mechanism of Rescue by Second-site Suppressor Mutations. J. Biol. Chem. 280: 16030-16037 [Abstract] [Full Text]  
• Shimizu, H., Burch, L. R., Smith, A. J., Dornan, D., Wallace, M., Ball, K. L., Hupp, T. R. (2002). The Conformationally Flexible S9-S10 Linker Region in the Core Domain of p53 Contains a Novel MDM2 Binding Site Whose Mutation Increases Ubiquitination of p53 in Vivo. J. Biol. Chem. 277: 28446-28458 [Abstract] [Full Text]  
• Joo, W. S., Jeffrey, P. D., Cantor, S. B., Finnin, M. S., Livingston, D. M., Pavletich, N. P. (2002). Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16: 583-593 [Abstract] [Full Text]  
• Schultz, L. B., Chehab, N. H., Malikzay, A., Halazonetis, T. D. (2000). p53 Binding Protein 1 (53BP1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks. J. Cell Biol. 151: 1381-1390 [Abstract] [Full Text]  
• Lopez, C. D., Ao, Y., Rohde, L. H., Perez, T. D., O'Connor, D. J., Lu, X., Ford, J. M., Naumovski, L. (2000). Proapoptotic p53-Interacting Protein 53BP2 Is Induced by UV Irradiation but Suppressed by p53. Mol. Cell. Biol. 20: 8018-8025 [Abstract] [Full Text]  
• Yang, J.-P., Hori, M., Sanda, T., Okamoto, T. (1999). Identification of a Novel Inhibitor of Nuclear Factor-kappa B, RelA-associated Inhibitor. J. Biol. Chem. 274: 15662-15670 [Abstract] [Full Text]  
• Gudas, J. M., Payton, M., Thukral, S., Chen, E., Bass, M., Robinson, M. O., Coats, S. (1999). Cyclin E2, a Novel G1 Cyclin That Binds Cdk2 and Is Aberrantly Expressed in Human Cancers. Mol. Cell. Biol. 19: 612-622 [Abstract] [Full Text]  
• Wing, B. A., Johnson, R. A., Huang, E.-S. (1998). Identification of Positive and Negative Regulatory Regions Involved in Regulating Expression of the Human Cytomegalovirus UL94 Late Promoter: Role of IE2-86 and Cellular p53 in Mediating Negative Regulatory Function. J. Virol. 72: 1814-1825 [Abstract] [Full Text]  
• Ruaro, E. M., Collavin, L., Del Sal, G., Haffner, R., Oren, M., Levine, A. J., Schneider, C. (1997). A proline-rich motif in p53 is required for transactivation- independent growth arrest as induced by Gas1. Proc. Natl. Acad. Sci. USA 94: 4675-4680 [Abstract] [Full Text]  
• Gorina, S., Pavletich, N. P. (1996). Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2. Science 274: 1001-1005 [Abstract] [Full Text]  
• Datta, B., Li, B., Choubey, D., Nallur, G., Lengyel, P. (1996). p202, an Interferon-inducible Modulator of Transcription, Inhibits Transcriptional Activation by the p53 Tumor Suppressor Protein, and a Segment from the p53-binding Protein 1That Binds to p202 Overcomes This Inhibition. J. Biol. Chem. 271: 27544-27555 [Abstract] [Full Text]